Myrbetriq
Chemical Name | mirabegron |
Dosage Form | Tablet (oral; 25 mg, 50 mg); Suspension (oral; 8 mg/mL) |
Drug Class | Receptor agonists |
System | Urinary |
Company | Astellas Pharma |
Approval Year | 2012 |
Indication
- For the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency